Aim To select a good inoculation method of BT-474 cell to establish a stable animal model of ErbB2-overexpressing human breast cancer in nude mice.Methods 36 nude mice received implants of 0.5 mg 17β-estradiol 60 d-release estrogen pellets and were randomly divided into three groups.The next day 5×10 6 BT-474 cells were injected into left second mammary fat pad of every mouse in the orthotopic group,left flank in the flank group or left axilla in the axilla group,respectively.The tumor growth and histopathological features of BT-474 xenografts in the three groups were observed and compared,and ErbB2 expression on tumor cell surface was evaluated by immunohistochemistry. Results The tumor-bearing rate of the nude mice in the three groups were all 100%,and the breast cancer xenografts all remained stable ErbB2 overexpression.However,the xenografts in the orthotopic group had less variance in tumor size,form and biological characteristics such as potent cell proliferation and angiogenesis compared with the control.Moreover,the orthotopic xenografts had a good response to the drugs.Conclusion The human breast cancer model established by orthotopic inoculation of BT-474 cell is more suitable than that in the flank or axilla for the pharmacological research of ErbB2-targeted therapeutics.